This nonsense about marketing and partnering is utterly flawed and / or Big Pharma interests trying to get at LLmab... Nobody will need to market a cure for corona or AIDS. They must think we're stupid.

Quote:

---

However, I'm not sure Daiichi Sankyo would have the marketing sale force necessary to promote, sell, and distribute leronolimab for the Combo HIV indication (followed, of course, by Mono).

Given the options, I would think an international sales and distribution deal with a Big Pharma would offer more advantages, and a consolidation of the entire supply chain under one banner. But that's an uneducated assumption on my part.

---

Get bent, pharma moles